| Rhoda Estrella-itchon, M.d., Inc. | |
|
25495 Medical Center Dr Suite 301 Murrieta CA 92562-4902 | |
| (951) 461-1070 | |
| Not Available |
| Full Name | Rhoda Estrella-itchon, M.d., Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 25495 Medical Center Dr, Murrieta, California |
| Authorized Official Name and Position | Rhoda Estrella-itchon (PRESIDENT) |
| Authorized Official Contact | 9514611070 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rhoda Estrella-itchon, M.d., Inc. 25495 Medical Center Dr Suite 301 Murrieta CA 92562-4902 Ph: () - | Rhoda Estrella-itchon, M.d., Inc. 25495 Medical Center Dr Suite 301 Murrieta CA 92562-4902 Ph: (951) 461-1070 |
| NPI Number | 1023202371 |
|---|---|
| Provider Enumeration Date | 08/30/2007 |
| Last Update Date | 06/17/2010 |
| Medicare PECOS PAC ID | 4183883713 |
|---|---|
| Medicare Enrollment ID | O20120316000498 |
News Archive
Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma - an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.
Today's headlines include an exclusive AP report detailing a "twist" in the health law that would allow millions of middle class Americans - mainly early retirees - access to Medicaid.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023202371 | NPI | - | NPPES |
| 6723134 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A55570 (California) | Primary |
| Provider Name | Rhoda G Estrella-itchon |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1245233147 PECOS PAC ID: 4587555867 Enrollment ID: I20040324000865 |
News Archive
Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma - an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.
Today's headlines include an exclusive AP report detailing a "twist" in the health law that would allow millions of middle class Americans - mainly early retirees - access to Medicaid.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.
› Verified 2 days ago
News Archive
Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma - an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.
Today's headlines include an exclusive AP report detailing a "twist" in the health law that would allow millions of middle class Americans - mainly early retirees - access to Medicaid.
Researchers have demonstrated the efficacy of the "French" functional method for correcting congenital idiopathic clubfoot, with the majority of patients achieving a good result, often without surgery.
Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.
› Verified 2 days ago
Murrieta Express Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 24910 Las Brisas Rd, Suite 105, Murrieta, CA 92562 Phone: 951-231-1385 Fax: 951-461-9191 | |
California Care Internal Medicine Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 24910 Las Brisas Rd, Suite 120, Murrieta, CA 92562 Phone: 951-677-9898 | |
Munif Salek, M.d. Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 28078 Baxter Rd, Ste. 324, Murrieta, CA 92563 Phone: 951-566-5646 Fax: 951-566-5670 | |
Scripps Clinic Temecula Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25405 Hancock Ave, Ste 216, Murrieta, CA 92562 Phone: 858-554-9100 | |
Tuan Ngoc Nguyen Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 28078 Baxter Rd, Suite 320, Murrieta, CA 92563 Phone: 951-246-4546 Fax: 951-672-9036 | |
Motion Sports Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25495 Medical Center Dr, Suite 305, Murrieta, CA 92562 Phone: 951-790-0107 Fax: 951-667-1933 |